Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 254039Generated: October 29, 2026

4-Methylmorpholine → n-{[4-((2r,3r)-1-(4-Chlorophenyl)-3-{[2-(4-chlorophenyl)-2-hydroxyethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycyl-d-lysine

https://huagongshe.com/reaction/254039

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-MethylmorpholineHCID 7972—
ReactantPotassium bisulfateHCID 516920—
ReactantAmmonium AcetateHCID 517165—
ReactantO-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborateHCID 2733207—
ReactantSodium borohydrideHCID 4311764—
ReactantTert-butyl n6-(tert-butoxycarbonyl)-d-lysinateHCID 7019751—
ReactantN-{[4-((2R,3R)-1-(4-chlorophenyl)-3-{[2-(4-chlorophenyl)-2-oxoethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycineHCID 66842755—
Reactant(tert-butoxycarbonyl)-D-lysinate hydrochlorideHCID 87176302—
SolventWaterHCID 962—
SolventDichloromethaneHCID 6344—
Productn-{[4-((2r,3r)-1-(4-Chlorophenyl)-3-{[2-(4-chlorophenyl)-2-hydroxyethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycyl-d-lysineHCID 66842794—

Reaction Steps

N-{[4-((2R,3R)-1-(4-Chlorophenyl)-3-{[2-(4-chlorophenyl)-2-oxoethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycine (14.6 mg, 0.026 mmol) and N-methylmorpholine (20 μl, 0.18 mmol) were dissolved in DCM (2 ml). tert-Butyl ff-(tert-butoxycarbonyl)-D-lysinate hydrochloride (11.1 mg, 0.033 mmol) was added and after 5 minutes TBTU (9.8 mg, 0.031 mmol) was added to the suspension. The mixture was stirred overnight. Additional tert-butyl N6-(tert-butoxycarbonyl)-D-lysinate (4.8 mg, 0.014 mmol), N-methylmorpholine (10 μl, 91 μmol) and TBTU (4.6 mg, 0.014 mmol) were added and the mixture was stirred for 2.5 h. The formation of the ester was confirmed. M/z: 855.4 (M−H). DCM (3 ml) and water (5 ml) were added and the solution was acidified to pH 3 with KHSO4 (2M). The organic phase was washed with water (2×5 ml). The combined water phases were extracted with DCM (2×5 ml). The organic phase was dried over Na2SO4, filtered and concentrated under reduced pressure. The oily residue was dissolved in DCM (1.5 ml) and TFA (1 ml) was added. The mixture was stirred for 2.5 h. The mixture was concentrated and co-evaporation with toluene was performed to assist the removal of TFA. The residue was dissolved in methanol (2 ml) and sodium borohydride (10.4 mg, 0.027 mmol) was added. After 15 minutes, ammonium acetate buffer (0.1M, 1.5 ml) was added and the solvent was removed under reduced pressure. The residue was purified with preparative HPLC on a C8 column. A gradient from 20% to 50% MeCN in 0.1M ammonium acetate buffer was used as eluent. After lyophilisation, the title compound was obtained as a white solid (10.8 mg, 59%). H-NMR (400 MHz, DMSO-d6): 1.18-1.36 (m, 2H), 1.41-1.70 (m, 4H), 2.71 (t, 2H), 2.84-2.97 (m, 2H), 3.72-3.75 (brd, 2H), 3.93 (m, 1H), 4.30 (d, 0.5H), 4.34 (d, 0.5H), 4.52 (s, 2H), 4.68-4.77 (m, 1H), 5.03 (d, 0.5H), 5.07 (d, 0.5H), 6.98 (d, 2H), 7.20 (d, 2H), 7.31-7.38 (m, 8H), 7.63-7.72 (m, 1H), 8.34 (t, 1H). M/z: 705.1.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07871998B2
Source datasetuspto-grants-2011_01
ORD IDord-ab71e0a50aa34b1e9d833412af31d4a0
Source noteuspto-grants-2011_01